InvestorsHub Logo
Post# of 89565
Next 10
Followers 127
Posts 10862
Boards Moderated 0
Alias Born 12/08/2000

Re: None

Monday, 01/15/2001 6:15:56 PM

Monday, January 15, 2001 6:15:56 PM

Post# of 89565
DNAP looks like it might be a good one to get into at least short term. I have seen a lot of interest for this stock on many boards this weekend.

I have no position. I figured that many of you might get bored with my SKGV and RMOO posts. So I have this one for you.

Good luck.



HERE IS WHY TO BUY DNAP...Listing on bb expected this week!

DNAP NEWINVESTORS GUIDE—DD LINKS

MAJOR WEB PAGES RELATED TO DNAP
dnap
http://www.dnaprint.com/
orchid biosciences inc
http://www.orchidbio.com/
orchid&exelixis develop snp code(™)kits
http://cnbc.com/news/news/conewsstory.html?sym=ORCH&id=010p3336


INVEST IN DNAP
email for free investment package= hresources@dnaprint.com
or call 1-877-362-3453(toll free)
all general questions for dnap email steve wagoner
swagoner@tbfcorp.net
dnaps vast new market
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=47460
investment club web page=
http://clubs.yahoo.com/clubs/dnaprintgenomicsinvestors
sec filings for dnap from 3nov00
http://www.secinfo.com/$/SEC/Registrant.asp?CIK=1127354
do your homework before buying any penny stock!!!a must read
http://www.allstocks.com/copia/html/the_basics_of_otcbb.html
10-kt annual report for dnap filed 28nov2000
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=41181
cash rich biotechs—new york times—dec. 23--2000
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=48198
dun&bradstreet reports on dnap
http://dodge.telebase.com/cgi-bin/dandb.cgi?FIELD1=dnap+geonomics&FIELD3=FL&P=P0020HX&submit1=Find&U=%5BIP%5D&Q=FREDGARNOCHG&SERVICE=FREDGAR&R=HF0
dnap mission statement
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=9893
open house presentation-2dec00-sarasota florida
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=55002
2dec00 summary of open house events http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=42296
reports from craig hall, (director of financial analysis-Tampa Bay Financial)[craig’s phone number is 941 341-0136 http://www.ragingbull.altavista.com/mboard/boards.cgi?read=15868&board=DNAP
18 burning questions answered re dnaps future
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=41795
great dnap investor links:
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=22034
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=23118
how will dnap generate income
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=44208
dnap trade marks-existing and applied for
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=43546
2dec dnap applies for 1st of many patents
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=43524
dnap’s partial patents pending list and growing
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=21559

the human genome investors portal
http://www.loonycat.com/Genomics.htm
institutional investing in dnap
http://www.lionshares.com/secmasdetails.cfm?CUSIP=23324Q103&SEARCH=symbol&sort=net_chg&order=DESC&records=15&FirstRow=1&LastRow=15&SID=DSUD001%203046476467211222000161411%20%20%20%20%2016A13EDA73C5B25A6ACBCB49845D34DDC&PID=
2dec00-wallstreetreporter interview with dnap ceo dr. tony frudakis
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=41886
time magazine 15jan01 on genomics
http://www.time.com/time/health/
dnap a $50 stock? allstock.com thinks it could be—a must read
http://www.allstocks.com/stockmessageboard/ubb/Forum15/HTML/000006.html
biotechs ready to soar
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=39771
pink sheets.com features dnap
http://www.pinksheets.com/quote/company_profile.jsp?symbol=DNAP
Pollyanna says yes to biotech
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=57245

dnap links on yahoo—lots of good stuff
http://google.yahoo.com/bin/query?p=dnaprint+genomics&hc=0&hs=0
clearstation rates danp
http://www.clearstation.com/cgi-bin/details?Event=peek&Symbol=DNAP&Refer=http://www.purepennies.com/
sock the stocks profiles dnap
http://www.sockthestocks.com/profiles/dnap.htm
daily prices for last 12 months
http://www.clearstation.com/cgi-bin/stock_price_enum?Symbol=DNAP
insider trader looks at dnap
http://www.insidertrader.com/freestuff/search.asp?search=1&criteria=DNAP
purepenny&3bagger rate dnap
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=PCBM&read=132938
Pennystockprofits assess dnap
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=15730
tipreporter rates dnap http://www.tipreporter.com/search.php?search=dnap
dnap on stocktribes hotlist for 21 weeks
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=24335
analysts tips and reports on dnap
http://www.tipreporter.com/search.php?search=dnap
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=15730
rules for otcbb membership
http://www.otcbb.com/MarketMakerServices/Rules/ServiceRules.stm#6500
why is dnap unique in the bio tech sector??
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=22654
could this be dnaps story?? basics are certainly there
http://quote.ragingbull.altavista.com/quote.cgi?mode=c&1003=SSOL&time=9&compidx=aaaaa%3A0&x=19&y=9

fbi district for dnap(Miami)—basher complaints-305-944-0101


NEWSLINKS GENERAL FOR DNAP
dnap company news
http://www.bell2bell.newsalert.com/bin/digest?Symbol=DNAP& =bell2bell news
http://quicken.excite.com/investments/quotes/?s=DNAP&t=0 =excite news
http://biz.yahoo.com/n/D/DNAP.html =yahoo news
bioinform news service
http://www.bioinform.com/
online journal of bioinformatics
http://www.cpb.uokhsc.edu/ojvr/xmlpaper.html#Sites
NEWSLINKS SPECIFIC EVENTS FOR DNAP
dnap&univ of miami collaborate in personalized medicine research
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=46132

pharmacogenomics collaboration agreement with fla. doctors
http://quicken.excite.com/investments/news/story/bw/?story=/news/stories/bw/20001108/a2087.htm&symbol=DNAP

dnap in barrons http://www.sockthestocks.com/profiles/dnapbarrons.ht m


UPCOMING EVENTS RELATED TO DNAP
cambridge health institute conference—3-9march2001—san francisco,ca
http://www.genometriconference.com/
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=28822
http://www.healthtech.com/2001/hgp/

TECHNICAL SITES RELATED TO DNAP
what is pharmacogenomics
http://www.ornl.gov/hgmis/medicine/pharma.html
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=31311
dnap is about pharmacogenomics
http://www.nigms.nih.gov/funding/medforyou.html
mit tech review explores pharmagogenomics
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=54989
adding dna to the Rx mix
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=15981
dnap to the rescue—dangerous drugs
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=45628
gene therapy cures type 1 diabetes in rats
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=40149
dnap and breast cancer
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=39983
stem cell research
http://www.stemcellresearchnews.com/index.html
personalized medicine no longer science fiction
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=25033
safe drugs that fit like a glove
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=11203
snipping away at human disease
http://www.usnews.com/usnews/issue/001023/snips.htm
a dna tradegy—dnap is about changing this story
http://www.fortune.com/fortune/2000/10/30/dru.html
protein powerhouse—the future of dnap and medicine
http://www.redherring.com/mag/issue84/mag-athersys-84.html

DNAP’S IMPRESSIVE BRAIN TRUST-WATCH IT GROW
dr dc rao, renowned biostatistician joins dnap board
http://www.biostat.wustl.edu/biostat/raodc.html
http://quicken.excite.com/investments/news/story/bw/?story=/news/stories/bw/20001122/a2032.htm&symbol=DNAP
http://research.medicine.wustl.edu/OCFR/Research.nsf/Alphabetical/?OpenView&StartKey=R&Count=33
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=39979
dr. ramin mirashemi, a new dnap addition—check this track record!
http://www.google.com/search?q=Ramin+Mirhashemi&hl=en&lr=&safe=off&start=0&sa=N
dnap lands tech guru & statistical geneticist, dr k.n. ponnuswamy
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=36194
dr.s.c. chandra-recognized expert on stochastic processes-inventor
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=56267
dr.jose arena joins dnap scientific advisory board 03 oct 2000
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=23532
dnap consultant member-robert preston white,pa-c
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=41789
sivamani natarajan ph.d—statistical geneticist
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=43539
scientific advisory board makeup
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=41862


DNAP COMPARED TO ITS TECHNICAL EQUALS, AND RIVALS:
genomica(gnom)nasdq-ipo29sept00($19)now$22
http://www.bell2bell.newsalert.com/bin/digest?Symbol=GNOM&
rosetta inpharmatics(rsta)nasdaq-last$14-12dec00
http://quicken.excite.com/investments/quotes/?Mod=20&S1=N&ticker=&symbol=RSTA&button=Go&choice=on
informax(inunx)nasdq-ipo-03oct00($16)now$23
http://www.bell2bell.newsalert.com/bin/digest?Symbol=INMX&
decode genetics inc( dcgn-nasdaq) $12 last
http://quicken.excite.com/investments/quotes/?Mod=20&S1=N&ticker=&symbol=dcgn&choice=on
incite genomics(incy)nasdq $37
http://www.bell2bell.newsalert.com/bin/digest?Symbol=INCY&
genentech(dna)($172)-2for1split 5 oct00-263million share float---dnap float = 269 million
http://www.bell2bell.newsalert.com/bin/digest?Symbol=DNA&

DNAP IN EUROPE
http://www.8ung.at/zockstocks/index2.htm
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=21485
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=24168

WHERE IS DNAP LOCATED—HOW DO YOU GET THERE?
great air fare rates round trip to sarasota
http://leisure.travelocity.com/RealDeals/Details/0,2941,TRAVELOCITY_AIR_449,00.html
dnaps new upscale digs in swinging sarasota, fla
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=21059
motel shopper link for sunny sarasota area
http://www.roomsaver.com/roomsaver/city/index.html?state=FL&city=Sarasota
location map of coconut ave digs
http://maps.yahoo.com/py/maps.py?BFCat=&Pyt=Tmap&newFL=Use+Address+Below&addr=900+COCONUT+AVE&csz=SARASOTA%2CFLORIDA%2C+34234&country=us&Get%A0Map=Get+Map
avis rent a car sarasota
http://www.avis.com/cgi-bin/maps_and_directions/driving_maps/us_locations/mqinterconnect

INTELLIGENT ADVICE OR BIASED ROT?KNOW THE DIFFERENCE OR HOW TO USE THESE MESSAGE BOARDS

complain to the fbi-phone305-944-0101(miami field office)
email suspected lying-sham efforts,etc to your federal govt(it,s called the sec) at enforcement@sec.gov
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=PCBM&read=132869
get the mob out of microcaps
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=PCBM&read=132789
crush naked shorting –stop being screwed without even knowing it—read me
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=PCBM&read=132581
suspicious sounding codswallop?? ask them to take the universal basher quiz!!!!
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=PCBM&read=132816
dnap has unusually good promise—accounting for the sad fact that were in “basher heaven”-read me
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=PCBM&read=132818
sec offers tips on how to avoid scams on the internet—good article
http://www.sec.gov/consumer/cyberfr.htm


CONTENTS
1.BACKGROUND
2.FOUNDERS
3.PRODUCTS&SERVICES

1.BACKGROUND

DNAPrint genomics is a young e-biotech company based in southwest Florida. We are developing an informatics platform system that will provide dynamic solutions for disease gene discovery, genetic predisposition and genetic analysis testing. Our work has real-life application to the germinating field of Personalized Medicine and will help lay the foundation for a brand-new area of medical research called Phenomics.
The PhenomeSM platform system that we are developing will help identify an individual predisposed to develop cancer before the onset of illness so that lifestyles can be altered and/or preventative measures taken. It will be used to identify individuals who are incompatible with certain drug treatments before the drugs are prescribed and damage is done. It will be used to tease out important genetic determinants associated with complex genetic diseases, so that drugs can be developed to target these genes.
Our aim is ambitious. By partnering our platform with biotech/pharma, we will participate in the downstream profits generated from pharmaceutical products our platform has enabled. By marketing our platform directly to the public, we intend to make comprehensive genotype screening solutions accessible to people all over the world via the internet. Our system will enable a more holistic approach to using genomics information to improve peoples lives.
The patient of the future will have more information and power than ever imagined. The human genome project, the internet and recent technological advancements all contribute to make this possible, and we intend to take advantage of these synergies to become the primary conduit for the generation and distribution of personalized genetic information.

The Market
Pharmacogenomics is currently a 1 billion dollar industry and is projected to be a 10 billion dollar industry by the end of 2003. Several billions of dollars have been spent on the human genome project so far, and an equal amount will likely be spent trying to understand what all of the genomics information means (i.e. bioinformatics, proteomics and phenomics). Genomics is a multi billion dollar industry world-wide and the market for personalized medicine is expected to exceed $25 billion dollars by 2010. Recently congress has approved a $2.3 billion increase in NIH funding to a total of $18 billion dollars for the year 2000.

2.FOUNDERS
Tony Frudakis, Ph.D.(tfrudakis@dnaprint.com)
Chief Executive Officer, President and Laboratory Director. Dr. Tony Frudakis is a Phi Beta Kappa, Magna Cumme Laude graduate of the University of California system. He received his doctorate degree in molecular and cell biology from the University of California Berkeley and has 14 total years of experience as a molecular biologist. Dr. Frudakis' technical experience encompass a range of areas within biology, including the molecular biology of eukaryotic transcriptional regulation, the creation and study of transgenic animals, the development of novel nucleic acid isolation techniques and gene discovery protocols, bioinformatics processing and anatomical gene expression profiling. At Corixa Corporation in Seattle, WA he developed several new techniques for RNA fingerprinting, managed and executed high-throughput gene discovery programs for various cancers and was instrumental in the companies early success in attracting R and D partners. Founding GAFF biologic in 1998, Dr. Frudakis established a good reputation for high quality DNA sequencing and library construction/screening services, until its evolution into the DNAPrint Genomics that exists today. In all, his work has resulted in a patent portfolio for over 350 unique genes and 2 products

George Frudakis(gfrudakis@dnaprint.com)
Vice President of Business Affairs. George Frudakis has vast experience with start-up company development. He started and developed a successful multi-component company called GAFF group, which today enjoys over 15 million dollars annually in revenue. During his life’s work as an entrepreneur and businessman, George has learned how to run and successfully manage the financial and operational aspects of both small and large companies alike. He is a graduate from the California State University at Long Beach in California.

Myung Ho Kim, Ph.D. Mathematics(mkim@dnaprint.com)
Director of Informatics and Lead Mathemetician. Myung recieved his Ph.D. in Mathematics from the University of Michigan in Ann Arbor in 1988 and M.S. in Mathematics from The Ohio State University in Columbus Ohio. Most recently, Myung worked on the Ant World Server project supported by DARPA (Defense Advanced Research Progect Agency) and implemented Kolmogorov-Smirnov tests, linear/nonlinear regression, nonparametric analysis and modeling to a TREC 6 (Text Retrieval Conference) project using SAS, C/C++ and Perl languages. Prior to this, Myung simulated mathematical modeling for breast tumors and implemented/developed various image processing algorithms. He has served as an Honorary research Fellow in the Department of Mathematics and Information Science at the University of Auckland, New Zealand and a Visiting Research Scholor in the Department of Mathematics at the University of California at Santa Cruz in California. Prior to coming to the United States, Myung held the position of Assistant Professor in the Department of Mathematics at Sungkyunkwan University in Soel Korea.

Venkateswarlu Kondragunta, Ph.D. (vkondragunta@dnaprint.com)
Director of Biostatistics. Dr. Kondragunta obtained his Ph.D. in Statistics from the University of Madras, Madras, India. He most recently served as a Postdoctoral Fellow at the Schoolof Public Health, University of Texas, Houston, TX under the tutelage of Dr. Ranajit Chakraborty, one of the most famous and accomplished genetic mathematicians in the world. His research interests include variance components, linear regression models, general linear models, design and analysis, discriminant analysis, principal component analysis and statistical genetics. He has taught courses in Variance Components, Design and Analysis of Experiments and Linear Regression Models and Probability Theory at Concordia University in Montreal, Canada. Dr. Kondragunta is an accomplished programmer and has amassed considerable experience with implementing statistical genetic ideas into C++, S-plus, FORTRAN (7 years experience) and JAVA code. His most recent work used the REG, ANOVA, GLM, VARCOMP, CANDISC, CLUSTER, DISCRIM, FACTOR, PRINCOMP and LOGISTIC tools in the SAS computing environment on real and simulated data sets.
A partial list of publications for Dr. Kondragunta include:
Chaubey, Y.P. and K.Venkateswarlu. A numerical study of some robust estimators of variance components in one-way model. International Indian Statistical Association Conference proceedings, October 10-11, 1998, McMaster University, Hamilton, Canada.
Venkateswarlu, K. K.N.Ponnuswamy, and M.R.Srinivasan. Estimation of variance components based on diallel model. Mathematical Biosciences, V-150, 105-112.
Venkateswarlu, K, and K.N.Ponnuswamy. Estimation of variance components based on bio-model of diallel crosses (balanced). Communications in Statistics (Theory & Methods), Vol-27, 139-152.
Venkateswarlu, K. Estimation of variance components based on diallel model involving maternal and maternal interaction effects. Biometrical Journal, Vol-39, 287-295.

3.PRODUCTS&SERVICES
see dnap web page for a complete description of products & services http://www.dnaprint.com/
SNiPdocTM
High-throughput SNP profiling-To help us with our bottom line, we provide contract SNP profiling services to the drug development community. We call this service our SNiPdocTM service, and it is targeted towards pharmaceutical companies. Many pharmaceutical companies are seeking to enter into the field of Pharmacogenomics. This new field of study could have a dramatic impact on overall health care costs in the future. Furthermore, by having access to pharmacogenomics data, pharmaceutical companies can focus their clinical trials on segments of the population that are genetically receptive to the treatment. Experimental drugs can be targeted to individuals of a particular genotype, and genetic variations shown to underlie a poor-response to a trial drug could be used as a basis for eliminating the non-responding segment of the trial population from the study. In this way, pharmaceutical companies can reduce drug trial failures and the costs associated with them. Contracting this work out to service providers is a viable option for many smaller pharmaceutical companies who do not have the volume of work necessary to justify the price of the equipment and expertise. At DNAPrint Genomics, we offer multiple patient – multiple SNP sampling matricies designed on a custom, semi-custom or predefined basis. We can use our proprietary PhenomixM databases of medically relevant SNPs (numbering in the thousands of SNPs at present), or design chips for your application de-novo. We will work with your scientists to develop the experiments from beginning to end, that suit your needs, and we can handle your project from blood/tissue or DNA starting points. Data handling will be customized for each client; data can be deposited in our secure SNP relational databases system offering you the option of accessing your data over the internet. Alternatively, we can burn and hand-delivered CDs to you. As we develop our data mining algorithms, you will have access to some of the most revolutionary SNP pattern finding tools available anywhere. Using smart PhenomixSM could help you identify overlapping sets of genotypes associated with various phenotypes and/or phenotypic responses, which you might otherwise miss if you conducted your studies on your own or through another less-specialized facility.
DNAPrintTMSTaR
STR typing - (so-called DNA testing) for the public and forensic community, including paternity and maternity testing. STR typing differs from SNP profiling in that it looks at only a few inter-genic regions of DNA. Therefore, it is useful only for individual identification and pedigree analysis, and tells nothing about an individuals phenotype. This kind of testing is commonly referred to as DNA testing and is the basis for forensic DNA science used by local and federal law enforcement. We use 7 or 13-locus tests to offer up to 1 in 2 billion resolution power. All tests are performed on PE Applied Biosystems 310 genetic analyzer using PE Profiler and Profiler Plus AMPlFSTRTM kits.
SeaQuickTM
DNA sequencing - There are an abundance of contract DNA sequencing services in operation today. Ours is unique because we offer the customer a seamless web-based interface for submitting, retrieving, manipulating and storing their data files. To date, no other service of this kind exists because it is difficult to design software that is compatible with the complicated DNA sequencing files (called a chromatogram - a series of colored peaks with the corresponding nucleotide sequence identity above each peak). We operate our service through a unique web-capable relational database management system (RDMS), which will be available by early April. Our system is used to collect sequencing requests from customers though a web-based interface, use the requests to build sample sheets for sequencing and organize chromatogram files by customer, project and library. The customer will use the system, through web-pages, to make their orders and retrieve their data from remote locations or their home laboratory. All chromatogram files are processed through the phred basecalling algorithm to give reads and quality values. The resulting reads are then compared to a set of vector sequences (UniVec from NCBI) and the E. coli genome. Customers can retrieve chromatogram files and sequences as quality trimmed, vector masked or unedited files. E. coli sequences can be excluded.
Home DNA specimen Collection Kit
We manufacture a home DNA specimen collection kit called the DNAPrintTM kit. The kit enables the collection of DNA for indefinite storage. A foam tipped swab is used to rub the inside of the subjects cheek. Tiny cells rub off onto the swab and each cell contains DNA. The oral sample is then deposited by contact to a preservative card. The card is sealed in a tamper resistant pouch with a desiccant pack and can be indefinitely stored in a filing cabinet or safe. We use this system as a starting point for genetic analysis because of its durability and convenience. Only takes 10 minutes-bloodless,painless,convenenient

Interested in becoming a retailer? Call toll free 1(877)DNA-file (1-877-362-3453)

We also offer the kit for sale to the public.
It is useful for:
Child security, as a reference record or practical addition to a baby book or family album.
Genealogical "cornerstone" records for adults.
Estate planning, as evidence to disprove illegitimate paternity claims against your estate after death.
A gift for the person that has everything.
Collect and store your sample at home(ex. a filing cabinet) or send it to us for certified storage.










Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.